DUBLIN — US health information and clinical research company IQVIA plans to appoint 170 people in Ireland to work on “ensuring vaccines administrated post authorization are safe for the public,” according to state investment agency IDA Ireland. Barry Mulchrone, IQVIA Ireland’s head of pharmacovigilance oversight and analytics, said the company is “proud to play a role in the humanitarian effort to ensure the safety profile of vaccines used for Covid-19 are monitored to the highest international standards.” Ireland’s Deputy Prime Minister (Tánaiste) Leo Varadkar welcomed the IQVIA recruitment announcement, citing “positive indications recently regarding the potential for a Covid-19 vaccine.”